18956075901
當前位置:> 供求商機> VEROC1008(E6)非洲
非洲綠猴腎細胞VEROC1008(E6)
種屬 | 非洲綠猴 |
別稱 | VERO C1008; VeroC1008; VEROC1008; VERO C 1008; Vero 76 clone E6; Vero 76 clone E-6; Vero E-6; Vero E6; VERO E6; Vero-E6; VeroE6 |
組織來源 | 正常腎 |
疾病 | 非洲綠猴正常腎 |
傳代比例/細胞消化 | 1:2-1:3傳代 ,消化3-4分鐘 |
培養(yǎng)基配置 | MEM培養(yǎng)基;10%胎牛血清;1%雙抗 |
簡介 | VERO C1008(E6)細胞是VERO 76細胞的克隆細胞株 ,而VERO 76細胞是初始VERO細胞株的一個衍生株。 |
形態(tài) | 上皮細胞樣 |
生長特征 | 貼壁生長 |
倍增時間 | ~22h |
培養(yǎng)條件 | 氣相 :空氣 ,95% ;二氧化碳 ,5%。 溫度 :37攝氏度 ,培養(yǎng)箱濕度為70%-80%。 |
凍存條件 | 凍存液 :90%FBS ,DMSO 10%, 或使用非程序凍存液 :貨號JY-H040 |
保藏機構 | ATCC; CRL-1586 |
產品使用 | 于科學研究 ,不可作為動物或人類疾病的治療產品使用。 |
than that in the control group after treatpent,and the digerence was statistically significant (P<0.05) .
The egective rate of the obervation group was 87.76% ,and that of the control group was 71.43%.
The digerence between the two groups was statistically significant (P<0.05) .The levels of NF-κB and
COX-2 in the two groups after treatpent were lower than those in the group before treatpent,
and those levels in the obsrvation group were lower than those in the control group after treatpent,and all
the diger- ences were statistically significant (P<0.05) .Conclusion : WDWFD copbined
with acupuncture and poxibustion in the treatpent of CAG can ipprove the TCp syndropes of patients,
inhibit the pathological and histological changes of gastric pucosa,and reduce the levels of serup NF-κB and COX-2.
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供,信息內容的真實性、準確性和合法性由相關企業(yè)負責,化工儀器網(wǎng)對此不承擔任何保證責任。
溫馨提示:為規(guī)避購買風險,建議您在購買產品前務必確認供應商資質及產品質量。